The Centers for Medicare & Medicaid Services will keep its Medicare GLP-1 Bridge program in place through the end of 2027, letting eligible beneficiaries access drugs like Wegovy and Zepbound for a ...

Faced with termination of its contract to provide Medicare and Medicaid services, Laurel Ridge Treatment Center is warning of ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

A ‘no gap’ private health arrangement sounds great, but you may not be able to choose your specialist. Here’s what else you ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity ...

A radiologist in Houston pulls up a chest X-ray and watches an algorithm flag a suspicious nodule before she has finished her ...

A new AHIP report outlines evidence-based strategies to cut chronic disease prevalence by 10% by 2035.

UnitedHealth is positioned for a sharp re-rating after a 48% drawdown driven by Medicare Advantage margin compression. Learn ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

Journal Editorial Report: The week's best and worst from Kim Strassel, Kyle Peterson, Allysia Finley and Dan Henninger. Photo: Damian Dovarganes/Associated Press The Trump Administration is ...

Medicare insurers’ shares surged Tuesday morning, as a substantial rate increase from the Trump administration convinced investors that the industry’s political prospects are looking up. Shares of ...